Navigation Links
InterMune Announces Proposed Public Offering of Common Stock
Date:11/4/2013

BRISBANE, Calif., Nov. 4, 2013 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that it plans to offer, subject to market and other conditions, 6,500,000 shares of its common stock in an underwritten public offering.  The company expects to grant the underwriters a 30-day option to purchase up to an additional 975,000 shares of common stock in connection with the offering.  All of the shares in the offering will be sold by InterMune.  The shares will be issued pursuant to a prospectus supplement filed as part of a shelf registration statement previously filed with the Securities and Exchange Commission (SEC) on Form S-3.  

InterMune intends to use the net proceeds from the offering to fund the commercialization of Esbriet® (pirfenidone) and its ASCEND clinical trial for U.S. registration of Esbriet, to advance the company's strategic initiatives including its new Esbriet formulations, its recently launched clinical trials supporting the use of Esbriet in idiopathic pulmonary fibrosis (IPF) and in potential new indications, its expanding anti-fibrotic research program with compounds intended to address IPF and other fibrotic diseases, and for general corporate purposes.

Goldman, Sachs & Co. and J. P. Morgan Securities LLC are acting as joint book-running managers of the proposed offering.  The common stock offering will be conducted by means of a prospectus supplement filed as part of an effective shelf registration statement filed with the Securities and Exchange Commission (SEC) on Form S-3.  Before investing in the offering, interested parties may read the prospectus supplement and the accompanying prospectus for such offering and the other documents InterMune has filed with the SEC, which are incorporated by reference in the prospectus supplement and the accompanying prospectus and
'/>"/>

SOURCE InterMune, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. InterMune to Divest Actimmune® (Interferon Gamma-1b)
2. InterMune Reports Second Quarter 2012 Financial Results and Business Highlights
3. InterMune Announces Presentations of New Research in IPF at ERS
4. Sean P. Nolan Joins InterMune as Executive Vice President and Chief Business Officer
5. InterMune Reports Second Quarter 2013 Financial Results And Business Highlights
6. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
7. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
8. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
9. Misonix Announces New Distribution Agreement For Panama
10. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
11. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... , May 4, 2015  Makindus, Inc. a ... that the European Medicines Agency (EMA) has granted orphan ... treatment of Stargardt,s Disease. "We are extremely ... to treat Stargardt,s disease in place for ... program in the United States ...
(Date:5/4/2015)... -- By looking at the brain, scientists believe it ... different conditions that can have very similar symptoms. ... a Denver -based psychiatrist specializing ... can help the medical community better identify the ... Stress Disorder (PTSD) and Traumatic Brain Injury (TBI). ...
(Date:5/4/2015)... -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) has entered ... to develop and commercialize ISIS-FXI Rx for the ... Isis is eligible to receive up to $155 million ... payment and a $55 million payment upon advancement of ... with compromised kidney function. Isis is also eligible to ...
Breaking Medicine Technology:European Medicines Agency (EMA) Grants Orphan Designation for Makindus' MI-100 for Stargardt's Disease 2New Medical Research Shows Brain Imaging Can Now Help Doctors Differentiate Between PTSD and Traumatic Brain Injuries 2New Medical Research Shows Brain Imaging Can Now Help Doctors Differentiate Between PTSD and Traumatic Brain Injuries 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5
... Equity Fund (EEF), a healthcare-focused private equity firm, and ... Inc. (MedTest), a medical diagnostic company based in Cortlandt ... diagnostics business from Polymedco, Inc.  The transaction was led ... not disclosed. "EEF is committed to building ...
... / PRNewswire / -- Silicon Valley ... life science companies worldwide, released a study ... private, venture capital-backed biotech and medical device companies. ... acquisition transactions of US venture-capital backed companies (60 biotech ...
Cached Medicine Technology:Enhanced Equity Fund and James White Invest in MedTest DX, Inc. 2Venture-Backed Biotech Generates Quicker Exits but Lower Multiples than Medical Device 2Venture-Backed Biotech Generates Quicker Exits but Lower Multiples than Medical Device 3
(Date:5/5/2015)... MA (PRWEB) May 05, 2015 Lauren ... goods retailer City Sports , was named one ... and active lifestyle industry by the SportsOneSource ... , Ms. Blanda, 33, is one of 40 executives ... Sporting Goods Business magazine) recognized for exceptional achievement in ...
(Date:5/4/2015)... Parlin, New Jersey (PRWEB) May 04, 2015 ... contest to give a chance to more youths to participate ... to encourage youths in her area to do good deeds ... behavior, Dr.Blagoev intends to empower their minds and teach them ... The contest is accessible to any youth 18 years of ...
(Date:5/4/2015)... NY (PRWEB) May 05, 2015 ... honors Irene Taylor , Volunteer Executive ... as a 2015-2016 inductee into its VIP Woman ... this prestigious distinction for leadership in business. NAPW ... professional women, boasting more than 700,000 members and ...
(Date:5/4/2015)... (PRWEB) May 05, 2015 The ... Patti Hommes as a 2015-2016 inductee into its ... with this prestigious distinction for leadership in business. NAPW ... women, boasting more than 700,000 members and over 200 ... with this important honor,” says NAPW President Star Jones. ...
(Date:5/4/2015)... 05, 2015 The National Association ... Betancourt as a 2015-2016 inductee into the NAPW ... with this prestigious distinction for leadership in business. NAPW ... women, boasting more than 700,000 members and over 200 ... with this important honor," said NAPW President Star Jones. ...
Breaking Medicine News(10 mins):Health News:Sporting Goods Trade Group Names City Sports’ Lauren Blanda to Its Annual “40 Under 40” List 2Health News:Sporting Goods Trade Group Names City Sports’ Lauren Blanda to Its Annual “40 Under 40” List 3Health News:10 More Days To Enter Good Deed Contest 2Health News:National Association of Professional Women Inducts Irene Taylor into its 2015-2016 VIP Woman of the Year Circle 2Health News:NAPW Inducts Patti Hommes, Director of Advancement Services, Springside Chestnut Hill Academy, a 2015-2016 Professional Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Gloria Betancourt, Receptionist at Consulate Health Care, into its 2015-2016 VIP Woman of the Year Circle 2
... N.C., Nov. 24 In January, victorious,politicians will go ... and health care, but patients don,t have to wait ... care. Instead, they should give,feedback directly to their doctors, ... "We don,t know whether ...
... LOS ANGELES, Nov. 24 To everyone around her, ... acting career, a successful clothing,line that was attracting international ... that for years, Melissa suffered from severe,breathing problems, extreme ... cause. , After ...
... easier, Fresho.com becomes a job search engine with the functionality of a ... ... Due to the current economic woes, employment sites are experiencing an increase ... increasing demand for new job openings, Fresho has changed its business concept ...
... A new study found that adolescents were at the greatest ... early age and the parents, smoking quickly reached high levels ... the November issue of Health Psychology , draws from ... research that suggests smoking behavior is influenced by both genetics ...
... ultrasound waves for deep vein thrombosis (DVT) may help dissolve ... according to researchers at Emory University. The study will be ... New York City. , "These clots are a main cause ... you can eliminate them the better," says Karthikeshwar Kasirajan, MD, ...
... its kind, researchers at the Yerkes National Primate ... have developed a multidisciplinary approach involving immunology, genomics ... vaccine without exposing individuals to infection. This approach ... vaccines--that of only being able to determine immunity ...
Cached Medicine News:Health News:Politicians May Not Listen ... But Doctors Do, Says DrScore 2Health News:Do You Have Genetic COPD? 2Health News:Fresho.com Adapts As The Online Recruiting Market Heats Up 2Health News:Smoking, teens and their parents: New research 2Health News:Ultrasound waves aid in rapid treatment of DVT 2Health News:Researchers discover strategy for predicting the immunity of vaccines 2
Total T3 EIA Thyroid Function 025-BC-1005...
... The anti-TG test kit is a solid ... format. It is designed for the quantitative ... (TG) in serum or plasma. The microplate ... Calibrators, controls and patient samples are pipetted ...
Free Estriol (E3) RIA Reproductive Hormones 024-IDC-2000...
... Hydroxyprogesterone (17aOHP) is produced by both ... 17aOHP has relatively little progestational activity, ... because it is the,immediate precursor to ... by 21-hydroxylation of 17aOHP,measurement of 17aOHP ...
Medicine Products: